leisure time -WSS

leisure time

author：comprehensive 2025-09-06 01:41:25 - browse：34

Dr. Peter Bach — Peter Bach, shown at the 2019 STAT summit, is now chief medical officer of Delfi. Emilie Pickering for STAT

Delfi Diagnostics, a well-funded startup in the burgeoning field of creating blood tests to detect cancer, said on Monday that it is launching a new test, FirstLook Lung, to try to identify people who could most benefit from lung cancer screening.

The approach represents a new one in the field of liquid biopsy, in which DNA fragments in blood are used to detect or learn about tumors. Grail, another company developing a blood test for cancer screening, has insisted that its product would be best used to detect multiple cancers at once. Other companies, including Exact Sciences and Freenome, are developing tests that would focus on detecting colorectal cancer. But Delfi appears to be the first to focus first on lung cancer, the leading cause of cancer death.

Delfi’s executives, in an interview with STAT, were clear that they view the initial launch as an opportunity to gather information, and not a real commercial coming out. The test will likely become available in limited ways with specific partners and will not initially be covered by insurance. Delfi declined to reveal a specific price, but said that its early access customers, which it is not yet disclosing, will be able to use FirstLook Lung for several hundred dollars. Such a rollout does not require approval from the Food and Drug Administration, which Delfi does not have.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Pharma showers House GOP doctor with campaign cash

Wikipedia

WSS

Boston's new lab space is opening empty

It costs an awful lot of money to give away a kidney

FDA approves Sage Therapeutics’ rapid

FDA approves Sage Therapeutics’ rapid

Amylyx ALS drug fails trial: Relyvrio patients react with fear, worry

HHS secretary Becerra pressed on Change HealthCare cyberattack

focus

leisure time

knowledge

23andMe had bad news about my health. I wish a person had delivered it

Ebola: Gilead Sciences antiviral shows promise as new treatment

Novavax promises a turnaround & Lilly roils the obesity market

How to save health care price transparency rules

Malaria cases in Florida and Texas: Here’s what you need to know

2 officers injured in shooting in Orlando, police say

23andMe had bad news about my health. I wish a person had delivered it

Alnylam reports growth in sales of rare disease treatments

Apple is now the first public company to be valued at $3 trillion

HHS secretary Becerra pressed on Change HealthCare cyberattack

Wikipedia

Chris Christie meets with Zelenskyy during Ukraine trip

Florida officials tell state schools to teach AP Psychology 'in its entirety'

Medicare slashes safety net hospital payments by nearly $1 billion

Medicare coverage of Wegovy, once blocked, now looks possible

Late stage cancers on the rise after pandemic delayed screenings

Listen: Biotech layoffs, eye drug drama, & gene therapy milestones

focus

Wikipedia

leisure time

focus